Effect of orlistat-induced weight loss on blood pressure and heart rate in obese patients with hypertension

Journal of Hypertension

Volumn 20, Issue 9, 2002, Pages 1873-1878

  Sharma, Arya M ^a   Golay, Alain ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Heart rate; Hypertension; Obesity; Orlistat; Systolic workload; Weight loss

Indexed keywords

PLACEBO; TETRAHYDROLIPSTATIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CALORIC RESTRICTION; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART RATE; HEART WORK; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTICENTER STUDY; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION;

EID: 0036735774     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200209000-00034     Document Type: Article

References (48)

1. Obesity: Preventing and managing the global epidemic
2. Overweight and obesity in the United States: Prevalence and trends, 1960-1994
3. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study
4. Blood pressure, stroke and coronary heart disease. Part 1, Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
5. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults
6. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure and effect of weight loss
7. Weight and blood pressure: Findings in hypertension screening of 1 million Americans
8. Weight and hypertension
9. Obesity, alcohol consumption and blood pressure in Australian men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study
10. The INTERSALT study: Relations of body mass index to blood pressure
11. Body weight, weight change and risk of hypertension in women
12. The relationship between body weight and blood pressure
13. Obesity and hypertension
14. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension
15. Weight reduction in a blood pressure clinic
16. The Hypertension Prevention Trial: Three-year effects of dietary changes on blood pressure
17. Effect of drug and diet treatment of mild hypertension on diastolic blood pressure
18. Sodium reduction and weight loss in the treatment of hypertension in older patients
19. Treatment of obesity by moderate and severe calorie restriction: Results of clinical research trials
20. Mode of action of orlistat
21. Randomised, placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
22. Role of orlistat in the treatment of obese patients with type 2 diabetes
23. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: A randomized controlled trial
24. Orlistat, a gastrointestinal lipase inhibitor, in the long-term treatment of obesity in a primary care setting
25. Weight loss, weight maintenance and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity
26. One-year treatment of obesity: A randomised, double-blind, placebo-controlled, multicentre study of orlistat
27. Obesity and hypertension: Epidemiological and clinical issues
28. Hypertension management in the Multiple Risk Factor Intervention Trial. 6-Year intervention results for men in special intervention and usual care groups
29. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I
30. Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension
31. Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: The Oslo Diet and Exercise Study
32. Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men
33. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, Phase II
34. Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients
35. Pharmacologic and nutritional treatment of mild hypertension: Changes in cardiovascular risk status
36. The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees
37. Cardiovascular changes after weight reduction in obesity hypertension
38. Rest heart rate and life expectancy
39. Heart disease and hypertension in severe obesity: The benefits of weight reduction
40. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygenic therapy in the Treatment of Mild Hypertension Study (TOMHS)
41. Pulmonary hypertension and dexfenfluramine
42. Appetite suppressants and valvular heart disease
43. Sibutramine - A review of clinical efficacy
44. Beneficial health effects of modest weight loss
45. Differentiated long-term effects of intentional weight loss on diabetes and hypertension
46. Blood pressure as a cardiovascular risk factor: Prevention and treatment
47. Insulin resistance and hypertension